
While that seems like a big amount, according to investigative reporter Greg Palast, it is truly an agreement that drug companies will scale back the quantity by which they improve their drug prices over the next 10 years, locking in a doubling of costs. US spending on prescribed drugs projected by the government for the following ten years is $3.6 trillion, in accordance with Palast, resulting in a very small saving — 2%, whereas most European nations are in a position to get 35-55% discount and the US Veterans are capable of get 40% discount. Different components of the world …









